Inmunomodulación y Microambiente Tumoral
ITAM
![Foto de Inmunomodulación y Microambiente Tumoral](/img/uploaded/c0b38ccda2541aecc1b9d759d57af663.jpg)
![Foto de Yale School of Medicine](/img/noimage_org.png)
Yale School of Medicine
New Haven, Estados UnidosPublications en collaboration avec des chercheurs de Yale School of Medicine (4)
2024
-
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports, Vol. 14, Núm. 1
2023
-
PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
Cancer Research, Vol. 83, Núm. 15, pp. 2513-2526
-
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
Nature Medicine, Vol. 29, Núm. 3, pp. 632-645
2020
-
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
Journal for ImmunoTherapy of Cancer, Vol. 8, Núm. 1